BioWave BioWraps

FDA 510(k) K261522 · Biowave Corporation

Substantially Equivalent

510(k) numberK261522

Submission

Device name
BioWave BioWraps
Applicant
Biowave Corporation
Westport, CT, US
Received
May 7, 2026
Decision date
June 3, 2026
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GXY – Electrode, Cutaneous
Device class
Class II (moderate risk)
Regulation
21 CFR 882.1320
Specialty
Neurology

Other 510(k)s with product code GXY

510(k)DeviceApplicantDecision
K262654Dexus Prosthetic System (MSL2, MSR2)GXY · Special Zhejiang Qiangnao Technology Co.,Ltd08/27/2026SE
K260578Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US)…GXY · Traditional Ambu A/S07/14/2026SE
K261442Charlotte ACC25 Surface Electrode Array; Charlotte ACC25 Reusable Surface Electrode ArrayGXY · Abbreviated Cadwell Industries, Inc.06/26/2026SE
K253237Elde Medical Electrodes (T5/ 5 cm x 5cm electrode T10/ 5 cm x 10cm electrode)GXY · Traditional Elde Medikal Sanayi ve Ticaret Anonim Sirketi05/08/2026SE
K254183MR Conditional Cup ElectrodesGXY · Traditional Technomed Europe05/07/2026SE
K252439Tutamen Self Adhesive ElectrodesGXY · Traditional Dongguan Tutamen Metalwork Co., Ltd.05/01/2026SE
K253256myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial…GXY · Traditional Otto Bock Healthcare Products GmbH04/22/2026SE
K260363Ceribell Brain Monitor HeadbandGXY · Abbreviated Ceribell, Inc.04/03/2026SE
K260453Remote Wave Electrode (AE03-50); Remote Wave Electrode (AE03-60)GXY · Special Bionit Labs Srl03/12/2026SE
K254033Ceribell Instant EEG HeadsetGXY · Abbreviated Ceribell, Inc.02/09/2026SE

More from Ceribell, Inc.

510(k)DeviceDecision
K203158BioWave BioWrapsGXY · Traditional 07/08/2021SE
K210202BioWaveGO RXGZJ · Special 02/24/2021SE
K180943BioWaveGOGZJ · Traditional 08/17/2018SE
K152437BiowaveHOME Neuromodulation Pain Therapy DeviceGZJ · Special 09/25/2015SE
K072123Homewave Neuromodulations Pain Therapy DeviceGZJ · Traditional 02/01/2008SE
K061166Deepwave Percutaneous Neuromodulation Pain Therapy SystemNHI · Traditional 08/15/2006SE
K052289Deepwave Neuromodulation Pain Therapy DeviceLIH · Traditional 12/13/2005SE

Questions and answers

When was BioWave BioWraps cleared by the FDA?

BioWave BioWraps (K261522) received a 510(k) decision of Substantially Equivalent on June 3, 2026, 27 days after the submission was received.

What is the product code of K261522?

The FDA product code is GXY – Electrode, Cutaneous, a Class II (moderate risk) device regulated under 21 CFR 882.1320.